Jiangxi Institute of Biological Products Inc. (SEHK: 6915)
Health Care · Biotechnology · CN
HK$14.00
+59.09% today · +43.1% 1Y
Jiangxi Institute of Biological Products Inc. (SEHK: 6915) operates in the Biotechnology industry within the Health Care sector. The company is valued at $550.16M.
Over the last twelve months the share price has gained 43.1%, trading between 3.95 and 17.02.
6915 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $550.16M
- Revenue (TTM)
- $33.66M
- P/E
- 36.12
- EPS
- 0.35
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$17.02
- 52-week low
- HK$3.95
- Avg volume (3M)
- —
- Shares outstanding
- 308.38M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $266.19 | +0.63% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $444.10 | +0.06% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.69 | +1.33% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $553.85 | +1.14% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $834.26 | +0.70% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.74 | +14.29% |
Figures last refreshed Aug 18, 2026.